research PUVA Treatment of Alopecia Areata Partialis, Totalis, and Universalis: Audit of 10 Years' Experience at St John's Institute of Dermatology
PUVA treatment is generally ineffective for alopecia areata.
Search
for
Sort by
Research
30 / 1000+ resultsresearch PUVA Treatment of Alopecia Areata Totalis and Universalis: A Retrospective Study
PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.
research Combination Therapy with Zinc Gluconate and PUVA for Alopecia Areata Totalis: An Adjunctive but Crucial Role of Zinc Supplementation
Zinc supplementation may be an important part of treating severe hair loss.
research Rapidly Progressive Alopecia Areata Totalis in a COVID-19 Patient, Unresponsive to Tofacitinib
A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.
research The Effect of Platelet-Rich Plasma on Hair Regrowth in Patients with Alopecia Areata Totalis: A Clinical Pilot Study
PRP did not significantly regrow hair in alopecia areata totalis patients.
research Contact Immunotherapy-Resistant Alopecia Areata Totalis/Universalis Reactive to Topical Corticosteroid
Topical corticosteroids can help treat severe alopecia areata when other treatments fail.
research Efficacy of Methotrexate Alone or With Low-Dose Prednisone in Alopecia Areata Totalis
Combining methotrexate with low-dose prednisone is more effective for hair regrowth in alopecia areata totalis.
research Mosaic Hair Regrowth Pattern of Ophiasis and Androgenic Alopecia in a Patient With Alopecia Areata Totalis
The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.
research 308-nm Excimer Laser for the Treatment of Alopecia Areata in Children
The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.
research Development of Alopecia Areata Universalis in a Patient Receiving Adalimumab
Adalimumab may cause severe hair loss in some patients.
research New Onset of Alopecia Areata in a Patient with SARS-CoV-2 Infection: Possible Pathogenetic Correlations
COVID-19 infection may trigger alopecia areata in some patients.
research Beard Alopecia Areata: A Multicenter Review of 55 Patients
Almost half of the men with beard hair loss also developed scalp hair loss within a year.
research Systemic Treatment for Alopecia Areata
Effective treatments for severe alopecia areata are still lacking.
research Pigmented Contact Dermatitis Due to Therapeutic Sensitizer as a Complication of Contact Immunotherapy in Alopecia Areata
Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.
research Alopecia Areata Possibly Induced by Autoimmune Reaction in a Patient with Human T-Cell Lymphotropic Virus-1-Associated Myelopathy
Autoimmune reactions may cause both alopecia areata and HAM.
research The Successful Treatment of Alopecia Areata with Platelet-Rich Plasma in Twins with Genetic Risk for Autoimmune Disorders
PRP injections can effectively treat alopecia areata.
research Extensive Alopecia Areata: A Multicenter Review of 132 Patients
The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.
research Alopecia Areata
Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.
research Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients
Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.
research Alopecia Areata: Treatment Options and Efficacy
Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.
research Interventions for Alopecia Areata
Current treatments for alopecia show no significant long-term benefits.
research Medium-Dose Prednisolone Pulse Therapy in Alopecia Areata
Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.
research High-Dose Pulsed Corticosteroid Therapy Combined with Methotrexate for Severe Alopecia Areata in Childhood
High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.
research Mild-To-Moderate COVID-19 Is Not Associated With Worsening Of Alopecia Areata: A Retrospective Analysis Of 32 Patients
COVID-19 doesn't make alopecia areata worse.
research Prognostic Factors in Mexican Patients with Patchy and Other Types of Alopecia Areata
Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.
research Herbal Lotions to Regrow Hair in Patients with Intractable Alopecia Areata
Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.
research Treatments for Alopecia Areata: A Network Meta-Analysis
The analysis aims to identify the most effective and safest treatments for alopecia areata.
research Alopecia Areata: Genetic and Immunological Insights
Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.
research An Overview of Alopecia Areata: Etiopathogenesis, Diagnosis, and Management
Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.
research Alopecia Areata: A Review of Treatments and Their Efficacy
Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.